New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Panacea Life Sciences Holdings, Inc.
PLSH
Shape
US Flag

OTC

1M

Drug Manufacturers - Specialty & Generic

Next Earning date - 10 Nov 2025

1M

Drug Manufacturers - Specialty & Generic

Next Earning date - 10 Nov 2025

0.07USD

Shape-0.05 ( -40.14%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

741%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

40%

Quote Panel

Shape
Updated October 18, 2025
1W 34.62 % 1M 7.69 % 3M 80.88 % 1Y -12.50 %

Key Metrics

Shape
  • Market Cap

    1.49M


  • Shares Outstanding

    21.22M


  • Share in Float

    10.13M


  • Dividende

    0


  • Earning Date

    10 Nov 2025


  • Price Target

    0.07


  • Average Volume

    4993


  • Beta

    3.302


  • Range

    0.025-0.11693


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.panacealife.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

PLSH

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$5M

Shape5%

2026-Revenue

$22.40

Shape9%

2026-EPS

$2M

Shape-5%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Price Target

N/A(N/A)

Number of analyst

N/A

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.12
vs -0.19

Q2.23

arrow
arrow

N/A

-0.11
vs -0.13

Q3.23

arrow
arrow

N/A

-0.13
vs -0.18

Q4.23

arrow
arrow

N/A

-0.13
vs -0.12

Q1.24

arrow
arrow

N/A

-0.09
vs -0.12

Q2.24

arrow
arrow

N/A

-0.07
vs -0.11

Q3.24

arrow
arrow

N/A

-0.06
vs -0.13

Q4.24

arrow
arrow

+228%

0.17
vs -0.13

Q1.25

arrow
arrow

N/A

-0.00
vs -0.09

Q2.25

arrow
arrow

+229%

0.09
vs -0.07

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

+45%

677.5K  vs 466.5K

Q2.23

arrow
arrow

-15%

399.1K  vs 469.5K

Q3.23

arrow
arrow

-5%

347.9K  vs 366.2K

Q4.23

arrow
arrow

+196%

960.5K  vs 324.8K

Q1.24

arrow
arrow

+56%

1.1M  vs 677.5K

Q2.24

arrow
arrow

+194%

1.2M  vs 399.1K

Q3.24

arrow
arrow

+173%

949K  vs 347.9K

Q4.24

arrow
arrow

-3%

928K  vs 960.5K

Q1.25

arrow
arrow

-44%

595.9K  vs 1.1M

Q2.25

arrow
arrow

-82%

215.1K  vs 1.2M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

+70%

0.7
vs 0.8

Q2.23

arrow
arrow

+33%

0.33
vs 0.7

Q3.23

arrow
arrow

+35%

0.35
vs 0.33

Q4.23

arrow
arrow

+27%

0.27
vs 0.35

Q1.24

arrow
arrow

+15%

0.15
vs 0.27

Q2.24

arrow
arrow

+13%

0.13
vs 0.15

Q3.24

arrow
arrow

+9%

0.09
vs 0.13

Q4.24

arrow
arrow

-42%

-0.42
vs 0.09

Q1.25

arrow
arrow

+0%

0
vs -0.42

Q2.25

arrow
arrow

-10%

-0.10
vs 0

Institutionnal OwnershipShape

status-upN/A

Q3.23

arrow
arrow

NA

NA
vs NA

NA

Q4.23

arrow
arrow

NA

NA
vs NA

NA

Q1.24

arrow
arrow

NA

NA
vs NA

NA

Q2.24

arrow
arrow

NA

NA
vs NA

NA

Q3.24

arrow
arrow

NA

NA
vs NA

NA

Q4.24

arrow
arrow

NA

NA
vs NA

NA

Q1.25

arrow
arrow

NA

NA
vs NA

NA

Q2.25

arrow
arrow

NA

NA
vs NA

NA

Q3.25

arrow
arrow

NA

NA
vs NA

NA

Q4.25

arrow
arrow

NA

NA
vs NA

NA

Earnings Growth

Latest News